\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ pt\\ was\\ noted\\ to\\ be\\ hypoxemic\\.\\ \\(note\\:\\ further\\ h\\&p\\ records\\ unavailable\\)\ \(0\)\
\-\ labs\\:\\ \ \(3\)\
\-\ cbc\\ \\‚\\Ä\\ì\\ 10\\.0\\/16\\.1\\/48\\.6\\/201\\;\\ cmp\\ \\‚\\Ä\\ì\\ bun\\ 29\\ \\(o\\/w\\ \\~wnl\\)\ \(0\)\
\-\ afb\\ culture\\ \\‚\\Ä\\ì\\ negative\\ p\\ 6\\ wks\\;\\ mycology\\ \\‚\\Ä\\ì\\ no\\ fungal\\ growth\\ p\\ 6\\ wks\\;\\ bacteriology\\ \\(bronchial\\ washing\\)\\ \\‚\\Ä\\ì\\ few\\ gm\\ neg\\ rods\ \(0\)\
\-\ histology\\ \\‚\\Ä\\ì\\ squamous\\ cell\\ ca\\ and\\ squamous\\ cell\\ ca\\ in\\-situ\ \(0\)\
\-\ radiation\\ therapy\ \(165\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ chemotherapy\\ \\(carboplatin\\,\\ taxol\\)\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ bronchoscopy\\ repeated\\ with\\ radiologic\\ follow\\-up\\ \\(pt\\ most\\ recently\\ c\\ enlarging\\ nodules\\ at\\ site\\ of\\ treated\\ \\ \\ \\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ malignancy\\.\\)\ \(1\)\
\-\ cxr\\ \\‚\\Ä\\ì\\ increased\\ opacity\\ over\\ lower\\ t\\-spine\\ on\\ lateral\\ film\ \(0\)\
\-\ ct\\ \\‚\\Ä\\ì\\ spiculated\\ mass\\ \\(\\~2cm\\)\\ in\\ rll\\ c\\ reticular\\ stranding\\ in\\ contact\\ c\\ pleura\\;\\ no\\ chest\\ wall\\ invasion\ \(0\)\
\-\ pet\\ \\‚\\Ä\\ì\\ increased\\ radiotracer\\ uptake\\ along\\ posterior\\ aspect\\ of\\ r\\ mediastinum\\ in\\ region\\ of\\ r\\ atrium\ \(0\)\
\-\ non\\-small\\ cell\\ \\(squamous\\ cell\\)\\ carcinoma\\ of\\ the\\ lung\\ \\(rll\\)\\;\\ t3n2m0\\,\\ corresponding\\ to\\ stage\\ iii\\-a\ \(0\)\
\-\ based\\ upon\\ radiographic\\ demonstration\\ of\\ pulmonary\\ mass\\:\ \(0\)\
\-\ malignancy\\ \\(primary\\ versus\\ metastatic\\)\ \(0\)\
\-\ benign\\ neoplasm\ \(14\)\
\-\ granulomatous\\ disease\\ \\(e\\.g\\.\\,\\ tb\\,\\ fungal\\,\\ sarcoidosis\\)\ \(0\)\
\-\ other\\ inflammation\\ \\(e\\.g\\.\\,\\ pneumonia\\,\\ abscess\\)\ \(0\)\
\-\ congenital\\ abnormality\ \(6\)\
\-\ may\\ also\\ consider\\ foreign\\ body\\ or\\ mucus\\ plug\ \(0\)\
\-\ 74\\ y\\/o\\ male\\ \\(retired\\ o\\-8\\ physician\\)\\ c\\ hx\\ of\\ copd\\ and\\ s\\/p\\ cabg\\ and\\ mv\\ replacement\\ presents\\ c\\ sob\\ and\\ productive\\ cough\\.\\ \\(note\\:\\ further\\ h\\&p\\ records\\ unavailable\\)\ \(0\)\
\-\ based\\ upon\\ the\\ radiographic\\ findings\\ for\\ this\\ patient\\,\\ the\\ diagnostic\\ possibilities\\ included\\ the\\ differential\\ diagnosis\\ for\\ a\\ pulmonary\\ mass\\ \\(as\\ above\\)\\.\\ the\\ definitive\\ diagnosis\\ was\\ made\\ with\\ bronchoscopy\\ and\\ histologic\\ examination\\,\\ which\\ was\\ consistent\\ with\\ squamous\\ cell\\ carcinoma\\ of\\ the\\ lung\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ the\\ american\\ cancer\\ society\\ estimated\\ over\\ 160\\,000\\ deaths\\ in\\ the\\ united\\ states\\ from\\ lung\\ cancer\\ in\\ 2004\\,\\ and\\ 87\\%\\ of\\ all\\ deaths\\ from\\ lung\\ cancer\\ are\\ attributed\\ to\\ tobacco\\ use1\\.\\ lung\\ cancer\\ is\\ generally\\ categorized\\ histologically\\ into\\ one\\ of\\ four\\ major\\ types\\ of\\ carcinoma\\:\\ adenocarcinoma\\,\\ squamous\\ cell\\,\\ large\\ cell\\,\\ and\\ small\\ cell\\.\\ the\\ former\\ three\\ are\\ distinguished\\ from\\ the\\ latter\\ as\\ non\\-small\\ cell\\ tumors\\,\\ in\\ contradistinction\\ to\\ small\\ cell\\ carcinoma\\,\\ which\\ is\\ generally\\ faster\\ growing\\ and\\ will\\ more\\ likely\\ respond\\ to\\ chemotherapy\\.\\ small\\ cell\\ carcinoma\\ only\\ accounts\\ for\\ about\\ 20\\%\\ of\\ all\\ lung\\ cancers\\,\\ while\\ the\\ remaining\\ 80\\%\\ are\\ mostly\\ non\\-small\\ cell\\ tumors\\.\\ the\\ type\\ of\\ non\\-small\\ cell\\ carcinoma\\ seen\\ in\\ this\\ patient\\,\\ squamous\\ cell\\,\\ accounts\\ for\\ 20\\-30\\%\\ of\\ all\\ lung\\ cancers\\.\\ it\\ can\\ be\\ distinguished\\ histologically\\ based\\ upon\\ keratin\\ production\\ and\\ the\\ presence\\ of\\ intercellular\\ bridges\\ as\\ seen\\ on\\ light\\ microscopy\\.\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ in\\ terms\\ of\\ clinical\\ presentation\\,\\ cough\\ is\\ present\\ in\\ 45\\-75\\%\\ of\\ patients\\ with\\ lung\\ cancer2\\,\\ and\\ is\\ the\\ most\\ common\\ associated\\ symptom\\.\\ squamous\\ cell\\ carcinoma\\ in\\ particular\\ may\\ be\\ associated\\ with\\ elevated\\ serum\\ calcium\\ levels\\ \\(not\\ noted\\ in\\ this\\ patient\\)\\ secondary\\ to\\ production\\ of\\ a\\ parathyroid\\-like\\ hormone\\,\\ although\\ hypercalcemia\\ may\\ also\\ be\\ the\\ result\\ of\\ metastatic\\ bone\\ disease\\.\\ initial\\ workup\\ includes\\ a\\ chest\\ x\\-ray\\ with\\ two\\ views\\.\\ while\\ most\\ lesions\\,\\ even\\ those\\ less\\ than\\ 3\\ cm\\ in\\ diameter\\ \\(i\\.e\\.\\,\\ t1\\ lesions\\)\\ can\\ be\\ identified\\ with\\ radiographs\\,\\ ct\\ is\\,\\ of\\ course\\,\\ more\\ sensitive\\.\\ \ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ imaging\\ is\\ also\\ a\\ necessary\\ tool\\ in\\ terms\\ of\\ staging\\.\\ ct\\ is\\ helpful\\ for\\ identifying\\ the\\ most\\ common\\ sites\\ of\\ metastases\\ from\\ bronchogenic\\ carcinoma\\‚\\Ä\\îspecifically\\,\\ metastatic\\ liver\\ or\\ adrenal\\ disease\\,\\ and\\ these\\ organs\\ are\\ generally\\ assessed\\ regardless\\ of\\ whether\\ or\\ not\\ the\\ patient\\ is\\ symptomatic\\.\\ other\\ imaging\\ studies\\ for\\ staging\\ are\\ generally\\ reserved\\ for\\ patients\\ whose\\ presentation\\ may\\ suggest\\ involvement\\ of\\ other\\ organs3\\,\\ such\\ as\\ the\\ brain\\ or\\ the\\ bones\\.\\ pet\\ may\\ be\\ useful\\ in\\ finding\\ metastatic\\ disease\\,\\ and\\ according\\ to\\ one\\ source\\,\\ \\‚\\Ä\\úcurrently\\,\\ the\\ accuracy\\ of\\ pet\\ in\\ the\\ detection\\ of\\ m\\ stage\\ is\\ 96\\%\\‚\\Ä\\ù\\.4\\ this\\ patient\\‚\\Ä\\ôs\\ pet\\ scan\\ revealed\\ an\\ area\\ of\\ increased\\ radiotracer\\ uptake\\ consistent\\ with\\ malignancy\\ in\\ the\\ lower\\ lobe\\ of\\ the\\ right\\ lung\\,\\ and\\ was\\ otherwise\\ normal\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ treatment\\ options\\ and\\ prognosis\\ for\\ non\\-small\\ cell\\ carcinoma\\ of\\ the\\ lung\\ vary\\ depending\\ on\\ the\\ type\\ of\\ tumor\\,\\ the\\ degree\\ of\\ differentiation\\,\\ and\\ the\\ stage\\ of\\ disease\\.\\ this\\ patient\\ was\\ found\\ to\\ be\\ a\\ t3n2m0\\,\\ which\\ equates\\ to\\ a\\ stage\\ iii\\-a\\,\\ signifying\\ locally\\ advanced\\ disease\\.\\ while\\ stage\\ iii\\-a\\ is\\ technically\\ operable\\,\\ the\\ role\\ of\\ surgery\\ in\\ stage\\ iii\\ disease\\ is\\ somewhat\\ controversial\\.\\ additionally\\,\\ among\\ patients\\ with\\ non\\-small\\ cell\\ carcinoma\\ undergoing\\ surgical\\ resection\\,\\ there\\ is\\ a\\ 50\\%\\ relapse\\ rate\\.\\ treatment\\ options\\ other\\ than\\ surgery\\ include\\ radiation\\ and\\ chemotherapy\\.\\ radiation\\ therapy\\,\\ while\\ palliative\\,\\ does\\ not\\ improve\\ survival\\ over\\ the\\ long\\-term\\ for\\ most\\ patients\\ with\\ stage\\ iii\\ non\\-small\\ cell\\ lung\\ cancer\\.5\\ following\\ radiation\\ therapy\\,\\ this\\ patient\\ underwent\\ chemotherapy\\ with\\ carboplatin\\ and\\ taxol\\.\\ overall\\,\\ the\\ 5\\-year\\ survival\\ rate\\ associated\\ with\\ stage\\ iii\\-a\\ n2\\ disease\\ is\\ 10\\-15\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cell\\:\\ 0\\.048708479259632766\ \(0\)\
\-\ non\\-small\\:\\ 0\\.047759089159305455\ \(0\)\
\-\ iii\\-a\\:\\ 0\\.04133889061649002\ \(0\)\
\-\ \\‚\\Ä\\ì\\:\\ 0\\.04057602124210372\ \(0\)\
\-\ squamous\\:\\ 0\\.034308940269821855\ \(0\)\
\-\ stage\\:\\ 0\\.03418555150225882\ \(0\)\
\-\ lung\\:\\ 0\\.03191881632195335\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02555375032842063\ \(0\)\
\-\ c\\:\\ 0\\.023809661388394687\ \(0\)\
\-\ pet\\:\\ 0\\.021030645175522472\ \(0\)\
\-\ t3n2m0\\:\\ 0\\.02066944530824501\ \(0\)\
\-\ p\\:\\ 0\\.02056132063363744\ \(0\)\
\-\ taxol\\:\\ 0\\.019044246760624977\ \(0\)\
\-\ \\%\\:\\ 0\\.018694687299845324\ \(0\)\
\-\ carboplatin\\:\\ 0\\.01809356655404077\ \(0\)\
\-\ generally\\:\\ 0\\.018033787218712766\ \(0\)\
\-\ deaths\\:\\ 0\\.016468368006420733\ \(0\)\
\-\ records\\:\\ 0\\.014655496052766613\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.014363168980730904\ \(0\)\
\-\ wks\\:\\ 0\\.014319972386551671\ \(0\)\
\-\ e\\.g\\.\\:\\ 0\\.014319972386551671\ \(0\)\
\-\ histologically\\:\\ 0\\.014168651117764868\ \(0\)\
\-\ \\,\\:\\ 0\\.013963942418242257\ \(0\)\
\-\ rll\\:\\ 0\\.013892489252216492\ \(0\)\
\-\ \\(\\:\\ 0\\.013549575169873115\ \(0\)\
\-\ distinguished\\:\\ 0\\.01353105741205879\ \(0\)\
\-\ \\)\\:\\ 0\\.013384059875513343\ \(0\)\
\-\ cancer\\:\\ 0\\.013173107921991865\ \(0\)\
\-\ radiation\\:\\ 0\\.01315006447625949\ \(0\)\
\-\ disease\\:\\ 0\\.0130995314533712\ \(0\)\
\-\ terms\\:\\ 0\\.012941809045632283\ \(0\)\
\-\ accounts\\:\\ 0\\.012617892659979722\ \(0\)\
\-\ while\\:\\ 0\\.01260796829942468\ \(0\)\
\-\ unavailable\\:\\ 0\\.012543452570144832\ \(0\)\
\-\ bronchoscopy\\:\\ 0\\.012333341998773936\ \(0\)\
\-\ upon\\:\\ 0\\.01228314810607769\ \(0\)\
\-\ production\\:\\ 0\\.012140521135381272\ \(0\)\
\-\ cancers\\:\\ 0\\.012079617298562372\ \(0\)\
\-\ \\;\\:\\ 0\\.011872339908866316\ \(0\)\
\-\ malignancy\\:\\ 0\\.011613445525679424\ \(0\)\
\-\ most\\:\\ 0\\.011564098134396695\ \(0\)\
\-\ staging\\:\\ 0\\.011544427024281058\ \(0\)\
\-\ based\\:\\ 0\\.011460810183822839\ \(0\)\
\-\ may\\:\\ 0\\.010986684460129683\ \(0\)\
\-\ be\\:\\ 0\\.010813947319352292\ \(0\)\
\-\ survival\\:\\ 0\\.010741880232987663\ \(0\)\
\-\ h\\:\\ 0\\.010546378219062574\ \(0\)\
\-\ patients\\:\\ 0\\.01037080703102474\ \(0\)\
\-\ hypoxemic\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ 10\\.0\\/16\\.1\\/48\\.6\\/201\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ \\~wnl\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ mycology\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ \\~2cm\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ o\\-8\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ 160\\,000\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ use1\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ 45\\-75\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ cancer2\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ parathyroid\\-like\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ carcinoma\\‚\\Ä\\îspecifically\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ organs3\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ equates\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ operable\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ cancer\\.5\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ n2\\:\\ 0\\.010334722654122505\ \(0\)\
\-\ metastatic\\:\\ 0\\.01008726566760183\ \(0\)\
\-\ options\\:\\ 0\\.009735238756985771\ \(0\)\
\-\ fungal\\:\\ 0\\.009713222953117448\ \(0\)\
\-\ bacteriology\\:\\ 0\\.009522123380312488\ \(0\)\
\-\ washing\\:\\ 0\\.009522123380312488\ \(0\)\
\-\ t\\-spine\\:\\ 0\\.009522123380312488\ \(0\)\
\-\ intercellular\\:\\ 0\\.009522123380312488\ \(0\)\
\-\ bridges\\:\\ 0\\.009522123380312488\ \(0\)\
\-\ signifying\\:\\ 0\\.009522123380312488\ \(0\)\
\-\ iii\\:\\ 0\\.009405621053301855\ \(0\)\
\-\ radiotracer\\:\\ 0\\.009348662805777718\ \(0\)\
\-\ ca\\:\\ 0\\.009329980110234514\ \(0\)\
\-\ other\\:\\ 0\\.009236288622285807\ \(0\)\
\-\ r\\:\\ 0\\.009099752616262148\ \(0\)\
\-\ o\\/w\\:\\ 0\\.00870952410650247\ \(0\)\
\-\ in\\-situ\\:\\ 0\\.00870952410650247\ \(0\)\
\-\ faster\\:\\ 0\\.00870952410650247\ \(0\)\
\-\ is\\:\\ 0\\.008569496036344002\ \(0\)\
\-\ all\\:\\ 0\\.008500317078890823\ \(0\)\
\-\ keratin\\:\\ 0\\.008447925570377957\ \(0\)\
\-\ in\\:\\ 0\\.00839830353151739\ \(0\)\
\-\ mv\\:\\ 0\\.008234184003210366\ \(0\)\
\-\ contradistinction\\:\\ 0\\.008234184003210366\ \(0\)\
\-\ technically\\:\\ 0\\.008234184003210366\ \(0\)\
\-\ microscopy\\:\\ 0\\.008053468083131517\ \(0\)\
\-\ therapy\\:\\ 0\\.00803507900201857\ \(0\)\
\-\ uptake\\:\\ 0\\.00796010181639909\ \(0\)\
\-\ \\:\\:\\ 0\\.007950350405561536\ \(0\)\
\-\ \\.4\\:\\ 0\\.007896924832692453\ \(0\)\
\-\ rate\\:\\ 0\\.007809429051526009\ \(0\)\
\-\ gm\\:\\ 0\\.007758843899918263\ \(0\)\
\-\ relapse\\:\\ 0\\.007758843899918263\ \(0\)\
\-\ note\\:\\ 0\\.007732861729195288\ \(0\)\
\-\ for\\:\\ 0\\.007692817512056783\ \(0\)\
\-\ cough\\:\\ 0\\.007677033713500755\ \(0\)\
\-\ over\\:\\ 0\\.007651732438944769\ \(0\)\
\-\ retired\\:\\ 0\\.007635326296567939\ \(0\)\
\-\ tool\\:\\ 0\\.007635326296567939\ \(0\)\
\-\ radiographic\\:\\ 0\\.007604605842412036\ \(0\)\
\-\ tumors\\:\\ 0\\.007525712444713953\ \(0\)\
\-\ pt\\:\\ 0\\.007449387466899771\ \(0\)\
\-\ rods\\:\\ 0\\.0074215847294003484\ \(0\)\
\-\ categorized\\:\\ 0\\.0074215847294003484\ \(0\)\
\-\ increased\\:\\ 0\\.0073522325268452135\ \(0\)\
\-\ 5\\-year\\:\\ 0\\.007327748026383306\ \(0\)\
\-\ society\\:\\ 0\\.007159986193275836\ \(0\)\
\-\ latter\\:\\ 0\\.007159986193275836\ \(0\)\
\-\ whose\\:\\ 0\\.007159986193275836\ \(0\)\
\-\ associated\\:\\ 0\\.007091896466263899\ \(0\)\
\-\ former\\:\\ 0\\.007084325558882434\ \(0\)\
\-\ i\\.e\\.\\:\\ 0\\.007084325558882434\ \(0\)\
\-\ \\&\\:\\ 0\\.0070372517986903435\ \(0\)\
\-\ patient\\:\\ 0\\.007029476572584662\ \(0\)\
\-\ afb\\:\\ 0\\.007013253317597048\ \(0\)\
\-\ possibilities\\:\\ 0\\.007013253317597048\ \(0\)\
\-\ regardless\\:\\ 0\\.007013253317597048\ \(0\)\
\-\ 20\\-30\\:\\ 0\\.006946244626108246\ \(0\)\
\-\ assessed\\:\\ 0\\.006946244626108246\ \(0\)\
\-\ 96\\:\\ 0\\.006946244626108246\ \(0\)\
\-\ small\\:\\ 0\\.0069234769673427385\ \(0\)\
\-\ presentation\\:\\ 0\\.006901291053906406\ \(0\)\
\-\ locally\\:\\ 0\\.006882859841500654\ \(0\)\
\-\ are\\:\\ 0\\.0068281000734443245\ \(0\)\
\-\ 87\\:\\ 0\\.006822727022757921\ \(0\)\
\-\ 10\\-15\\:\\ 0\\.006822727022757921\ \(0\)\
\-\ this\\:\\ 0\\.006760636904905977\ \(0\)\
\-\ type\\:\\ 0\\.00675410135603027\ \(0\)\
\-\ mucus\\:\\ 0\\.006710991759212405\ \(0\)\
\-\ cabg\\:\\ 0\\.006710991759212405\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.006710991759212405\ \(0\)\
\-\ accuracy\\:\\ 0\\.006710991759212405\ \(0\)\
\-\ respond\\:\\ 0\\.0066588794935959535\ \(0\)\
\-\ reserved\\:\\ 0\\.0066588794935959535\ \(0\)\
\-\ controversial\\:\\ 0\\.0065611284866334075\ \(0\)\
\-\ reticular\\:\\ 0\\.0065151487525732885\ \(0\)\
\-\ plug\\:\\ 0\\.0065151487525732885\ \(0\)\
\-\ cmp\\:\\ 0\\.0064709045228161415\ \(0\)\
\-\ demonstration\\:\\ 0\\.0064709045228161415\ \(0\)\
\-\ productive\\:\\ 0\\.006428269535511482\ \(0\)\
\-\ vary\\:\\ 0\\.006387130825298972\ \(0\)\
\-\ further\\:\\ 0\\.006371498573974814\ \(0\)\
\-\ histologic\\:\\ 0\\.006347386919465817\ \(0\)\
\-\ attributed\\:\\ 0\\.006347386919465817\ \(0\)\
\-\ identifying\\:\\ 0\\.006271726285072416\ \(0\)\
\-\ contact\\:\\ 0\\.0062006540437870294\ \(0\)\
\-\ united\\:\\ 0\\.006166670999386968\ \(0\)\
\-\ neg\\:\\ 0\\.006133645352298227\ \(0\)\
\-\ spiculated\\:\\ 0\\.006101524632265268\ \(0\)\
\-\ palliative\\:\\ 0\\.006101524632265268\ \(0\)\
\-\ as\\:\\ 0\\.006061324763864609\ \(0\)\
\-\ pleura\\:\\ 0\\.006039808649281186\ \(0\)\
\-\ tobacco\\:\\ 0\\.006039808649281186\ \(0\)\
\-\ copd\\:\\ 0\\.006010127748947903\ \(0\)\
\-\ 6\\:\\ 0\\.0059838690770805955\ \(0\)\
\-\ histology\\:\\ 0\\.0059529294322193775\ \(0\)\
\-\ among\\:\\ 0\\.0059529294322193775\ \(0\)\
\-\ from\\:\\ 0\\.005938737224638745\ \(0\)\
\-\ role\\:\\ 0\\.005925343854950686\ \(0\)\
\-\ also\\:\\ 0\\.005924805136002877\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0058535763428371945\ \(0\)\
\-\ sob\\:\\ 0\\.005846280219785936\ \(0\)\
\-\ mostly\\:\\ 0\\.005846280219785936\ \(0\)\
\-\ detection\\:\\ 0\\.005821067786936037\ \(0\)\
\-\ repeated\\:\\ 0\\.005796386181780314\ \(0\)\
\-\ estimated\\:\\ 0\\.005796386181780314\ \(0\)\
\-\ was\\:\\ 0\\.005792951478392068\ \(0\)\
\-\ organs\\:\\ 0\\.00574852921282339\ \(0\)\
\-\ 74\\:\\ 0\\.005725313940494926\ \(0\)\
\-\ bronchial\\:\\ 0\\.005680218652302903\ \(0\)\
\-\ symptom\\:\\ 0\\.005680218652302903\ \(0\)\
\-\ hormone\\:\\ 0\\.005680218652302903\ \(0\)\
\-\ atrium\\:\\ 0\\.005636793949277874\ \(0\)\
\-\ which\\:\\ 0\\.0056101216432914965\ \(0\)\
\-\ according\\:\\ 0\\.005574531551488955\ \(0\)\
\-\ bun\\:\\ 0\\.0055347876456558\ \(0\)\
\-\ growing\\:\\ 0\\.0055347876456558\ \(0\)\
\-\ long\\-term\\:\\ 0\\.0055347876456558\ \(0\)\
\-\ sites\\:\\ 0\\.005459127011262398\ \(0\)\
\-\ consider\\:\\ 0\\.005440950942638758\ \(0\)\
\-\ sensitive\\:\\ 0\\.005440950942638758\ \(0\)\
\-\ one\\:\\ 0\\.005429616373530232\ \(0\)\
\-\ 2004\\:\\ 0\\.005388054769977012\ \(0\)\
\-\ whether\\:\\ 0\\.005388054769977012\ \(0\)\
\-\ particular\\:\\ 0\\.005370940116493831\ \(0\)\
\-\ lesions\\:\\ 0\\.005363565079352749\ \(0\)\
\-\ culture\\:\\ 0\\.005337442610697752\ \(0\)\
\-\ differentiation\\:\\ 0\\.005337442610697752\ \(0\)\
\-\ improve\\:\\ 0\\.005337442610697752\ \(0\)\
\-\ bronchogenic\\:\\ 0\\.00528892535845525\ \(0\)\
\-\ source\\:\\ 0\\.00528892535845525\ \(0\)\
\-\ than\\:\\ 0\\.005249821465224558\ \(0\)\
\-\ common\\:\\ 0\\.005243299441867285\ \(0\)\
\-\ 29\\:\\ 0\\.005227209375471168\ \(0\)\
\-\ useful\\:\\ 0\\.005227209375471168\ \(0\)\
\-\ radiologic\\:\\ 0\\.005212274995896221\ \(0\)\
\-\ remaining\\:\\ 0\\.005212274995896221\ \(0\)\
\-\ depending\\:\\ 0\\.005212274995896221\ \(0\)\
\-\ helpful\\:\\ 0\\.00518296514571402\ \(0\)\
\-\ m\\:\\ 0\\.005168580511960428\ \(0\)\
\-\ workup\\:\\ 0\\.005154370241699765\ \(0\)\
\-\ advanced\\:\\ 0\\.005126456233852499\ \(0\)\
\-\ types\\:\\ 0\\.005112744581140668\ \(0\)\
\-\ enlarging\\:\\ 0\\.0050991914481968515\ \(0\)\
\-\ corresponding\\:\\ 0\\.0050991914481968515\ \(0\)\
\-\ adrenal\\:\\ 0\\.005072546370731956\ \(0\)\
\-\ more\\:\\ 0\\.0050109643829124645\ \(0\)\
\-\ overall\\:\\ 0\\.004983786907970295\ \(0\)\
\-\ hx\\:\\ 0\\.004959614238330511\ \(0\)\
\-\ definitive\\:\\ 0\\.004947712278818181\ \(0\)\
\-\ foreign\\:\\ 0\\.004935929939013372\ \(0\)\
\-\ somewhat\\:\\ 0\\.004924264838364875\ \(0\)\
\-\ consistent\\:\\ 0\\.004912774370061437\ \(0\)\
\-\ undergoing\\:\\ 0\\.004912714666684908\ \(0\)\
\-\ calcium\\:\\ 0\\.004901277181403121\ \(0\)\
\-\ replacement\\:\\ 0\\.004889950204953254\ \(0\)\
\-\ surgery\\:\\ 0\\.004865179517843552\ \(0\)\
\-\ the\\:\\ 0\\.004862225722284612\ \(0\)\
\-\ stranding\\:\\ 0\\.004845705975196106\ \(0\)\
\-\ granulomatous\\:\\ 0\\.00483490098679643\ \(0\)\
\-\ serum\\:\\ 0\\.00483490098679643\ \(0\)\
\-\ invasion\\:\\ 0\\.0048241946754678565\ \(0\)\
\-\ mediastinum\\:\\ 0\\.0048241946754678565\ \(0\)\
\-\ tb\\:\\ 0\\.0048241946754678565\ \(0\)\
\-\ chest\\:\\ 0\\.004794206330732752\ \(0\)\
\-\ american\\:\\ 0\\.004772082409851404\ \(0\)\
\-\ versus\\:\\ 0\\.004761932277678937\ \(0\)\
\-\ prognosis\\:\\ 0\\.004751869272179065\ \(0\)\
\-\ noted\\:\\ 0\\.0047489359635465266\ \(0\)\
\-\ physician\\:\\ 0\\.004722188371845782\ \(0\)\
\-\ states\\:\\ 0\\.00471245941192234\ \(0\)\
\-\ 80\\:\\ 0\\.00471245941192234\ \(0\)\
\-\ or\\:\\ 0\\.00469647244531633\ \(0\)\
\-\ imaging\\:\\ 0\\.004694194195675504\ \(0\)\
\-\ degree\\:\\ 0\\.004693240408668324\ \(0\)\
\-\ opacity\\:\\ 0\\.004683747782369825\ \(0\)\
\-\ major\\:\\ 0\\.004683747782369825\ \(0\)\
\-\ recently\\:\\ 0\\.004674331402888859\ \(0\)\
\-\ light\\:\\ 0\\.004674331402888859\ \(0\)\
\-\ included\\:\\ 0\\.004619368230674497\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004600748723986916\ \(0\)\
\-\ those\\:\\ 0\\.004558340842683814\ \(0\)\
\-\ can\\:\\ 0\\.004544483827594536\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.0045248433368877345\ \(0\)\
\-\ x\\-ray\\:\\ 0\\.004516616405283225\ \(0\)\
\-\ few\\:\\ 0\\.004508446804678191\ \(0\)\
\-\ lower\\:\\ 0\\.004506124429926993\ \(0\)\
\-\ to\\:\\ 0\\.004505994110183911\ \(0\)\
\-\ pe\\:\\ 0\\.004500333741554423\ \(0\)\
\-\ cbc\\:\\ 0\\.004476326084645232\ \(0\)\
\-\ even\\:\\ 0\\.004460589835721268\ \(0\)\
\-\ necessary\\:\\ 0\\.004437374563392805\ \(0\)\
\-\ of\\:\\ 0\\.004370599795469671\ \(0\)\
\-\ growth\\:\\ 0\\.004355981238150409\ \(0\)\
\-\ four\\:\\ 0\\.004348854572175753\ \(0\)\
\-\ not\\:\\ 0\\.00434285582089778\ \(0\)\
\-\ additionally\\:\\ 0\\.0043417709678897475\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.004327730884599342\ \(0\)\
\-\ metastases\\:\\ 0\\.0042798739156424195\ \(0\)\
\-\ suggest\\:\\ 0\\.0042665518070254035\ \(0\)\
\-\ inflammation\\:\\ 0\\.0042599470969219375\ \(0\)\
\-\ site\\:\\ 0\\.004233894181582301\ \(0\)\
\-\ cxr\\:\\ 0\\.004227470423358824\ \(0\)\
\-\ bones\\:\\ 0\\.004227470423358824\ \(0\)\
\-\ diameter\\:\\ 0\\.004214727548520719\ \(0\)\
\-\ ct\\:\\ 0\\.004203881547685966\ \(0\)\
\-\ s\\/p\\:\\ 0\\.004202121696496965\ \(0\)\
\-\ mass\\:\\ 0\\.004179815968162595\ \(0\)\
\-\ nodules\\:\\ 0\\.0041530115655366365\ \(0\)\
\-\ pneumonia\\:\\ 0\\.0041410488806899294\ \(0\)\
\-\ levels\\:\\ 0\\.0041351130050081624\ \(0\)\
\-\ views\\:\\ 0\\.004129207033109034\ \(0\)\
\-\ treatment\\:\\ 0\\.004055373879486253\ \(0\)\
\-\ includes\\:\\ 0\\.004038546771206138\ \(0\)\
\-\ made\\:\\ 0\\.003990471714081428\ \(0\)\
\-\ symptomatic\\:\\ 0\\.003980050908199545\ \(0\)\
\-\ diagnostic\\:\\ 0\\.003969721916778496\ \(0\)\
\-\ currently\\:\\ 0\\.003969721916778496\ \(0\)\
\-\ seen\\:\\ 0\\.00395926756170619\ \(0\)\
\-\ about\\:\\ 0\\.0038617321290788415\ \(0\)\
\-\ film\\:\\ 0\\.0038477478724958706\ \(0\)\
\-\ result\\:\\ 0\\.0038431232789542338\ \(0\)\
\-\ 50\\:\\ 0\\.0038112520710947297\ \(0\)\
\-\ course\\:\\ 0\\.0037802244354696846\ \(0\)\
\-\ studies\\:\\ 0\\.003741501662109214\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.003741501662109214\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.003720529136023897\ \(0\)\
\-\ abnormality\\:\\ 0\\.0036958475308681736\ \(0\)\
\-\ above\\:\\ 0\\.0036716748612283896\ \(0\)\
\-\ involvement\\:\\ 0\\.0036716748612283896\ \(0\)\
\-\ congenital\\:\\ 0\\.003663726810835214\ \(0\)\
\-\ presence\\:\\ 0\\.003636325461262754\ \(0\)\
\-\ 20\\:\\ 0\\.003602010827851132\ \(0\)\
\-\ otherwise\\:\\ 0\\.0035982593592336983\ \(0\)\
\-\ and\\:\\ 0\\.0035875182854017747\ \(0\)\
\-\ identified\\:\\ 0\\.0035796800013907634\ \(0\)\
\-\ labs\\:\\ 0\\.0034841430327492823\ \(0\)\
\-\ benign\\:\\ 0\\.0034572688945289577\ \(0\)\
\-\ liver\\:\\ 0\\.003453952533215385\ \(0\)\
\-\ underwent\\:\\ 0\\.0034375100064222967\ \(0\)\
\-\ does\\:\\ 0\\.0034180786288206403\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0034116724219366095\ \(0\)\
\-\ elevated\\:\\ 0\\.003398964081311914\ \(0\)\
\-\ less\\:\\ 0\\.003392661200847224\ \(0\)\
\-\ although\\:\\ 0\\.003383269965505983\ \(0\)\
\-\ three\\:\\ 0\\.003377050678015135\ \(0\)\
\-\ initial\\:\\ 0\\.0033195570261187663\ \(0\)\
\-\ along\\:\\ 0\\.0033107313913933365\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.003259128946590553\ \(0\)\
\-\ a\\:\\ 0\\.0032546290887810188\ \(0\)\
\-\ body\\:\\ 0\\.0032535330746648115\ \(0\)\
\-\ finding\\:\\ 0\\.0032286770281811034\ \(0\)\
\-\ revealed\\:\\ 0\\.0032150924851888545\ \(0\)\
\-\ differential\\:\\ 0\\.003180492179780691\ \(0\)\
\-\ t1\\:\\ 0\\.0031752585418807077\ \(0\)\
\-\ radiographs\\:\\ 0\\.0031726504586191474\ \(0\)\
\-\ abscess\\:\\ 0\\.0031674516343895274\ \(0\)\
\-\ area\\:\\ 0\\.0031674516343895274\ \(0\)\
\-\ found\\:\\ 0\\.0031571226429684784\ \(0\)\
\-\ aspect\\:\\ 0\\.0031468838622313684\ \(0\)\
\-\ will\\:\\ 0\\.003134209869143191\ \(0\)\
\-\ such\\:\\ 0\\.0031316914300596158\ \(0\)\
\-\ resection\\:\\ 0\\.003124168412098732\ \(0\)\
\-\ examination\\:\\ 0\\.0031142122338506037\ \(0\)\
\-\ clinical\\:\\ 0\\.0030824264948018805\ \(0\)\
\-\ brain\\:\\ 0\\.0030144800976585717\ \(0\)\
\-\ only\\:\\ 0\\.003012205930228529\ \(0\)\
\-\ treated\\:\\ 0\\.002998652797284712\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.0029941696830544616\ \(0\)\
\-\ negative\\:\\ 0\\.0029919345385402978\ \(0\)\
\-\ primary\\:\\ 0\\.002967625161659667\ \(0\)\
\-\ wall\\:\\ 0\\.002901710574723032\ \(0\)\
\-\ s\\:\\ 0\\.002873115670708777\ \(0\)\
\-\ two\\:\\ 0\\.00286908703120282\ \(0\)\
\-\ following\\:\\ 0\\.0028432330092627764\ \(0\)\
\-\ region\\:\\ 0\\.0028295442288854777\ \(0\)\
\-\ likely\\:\\ 0\\.002825662328177792\ \(0\)\
\-\ include\\:\\ 0\\.002810262002380172\ \(0\)\
\-\ scan\\:\\ 0\\.0028045386406013815\ \(0\)\
\-\ secondary\\:\\ 0\\.0028007385304909815\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0027744771744661672\ \(0\)\
\-\ lobe\\:\\ 0\\.0026955748510240725\ \(0\)\
\-\ cm\\:\\ 0\\.002686935659808893\ \(0\)\
\-\ these\\:\\ 0\\.002607086391509777\ \(0\)\
\-\ on\\:\\ 0\\.00254592384184793\ \(0\)\
\-\ bone\\:\\ 0\\.0024893724284406446\ \(0\)\
\-\ into\\:\\ 0\\.0023837354841262683\ \(0\)\
\-\ 3\\:\\ 0\\.0023458095272057907\ \(0\)\
\-\ tumor\\:\\ 0\\.0023355595564018886\ \(0\)\
\-\ posterior\\:\\ 0\\.0023090721555714517\ \(0\)\
\-\ present\\:\\ 0\\.00226261284165496\ \(0\)\
\-\ it\\:\\ 0\\.0022518738388429267\ \(0\)\
\-\ large\\:\\ 0\\.0021905538473986864\ \(0\)\
\-\ lateral\\:\\ 0\\.0021649097838505865\ \(0\)\
\-\ findings\\:\\ 0\\.0021322824569636103\ \(0\)\
\-\ surgical\\:\\ 0\\.0021057699534014693\ \(0\)\
\-\ presents\\:\\ 0\\.002046476313608354\ \(0\)\
\-\ no\\:\\ 0\\.002017454046198832\ \(0\)\
\-\ male\\:\\ 0\\.0018114953550849625\ \(0\)\
\-\ with\\:\\ 0\\.0016460142005611687\ \(0\)\
\-\ normal\\:\\ 0\\.0015704718107844092\ \(0\)\
\-\ there\\:\\ 0\\.0014908740404044414\ \(0\)\
\-\ an\\:\\ 0\\.0013853046474615824\ \(0\)\
\-\ at\\:\\ 0\\.0013572838837416564\ \(0\)\
\-\ \\.\\:\\ 0\\.0010820491659214574\ \(0\)\
\-\ right\\:\\ 0\\.0010570125546429268\ \(0\)\
